{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,10,14]],"date-time":"2023-10-14T09:15:36Z","timestamp":1697274936414},"reference-count":19,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2009,9,24]],"date-time":"2009-09-24T00:00:00Z","timestamp":1253750400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["obgyn.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Aust NZ J Obst Gynaeco"],"published-print":{"date-parts":[[2009,10]]},"abstract":"<jats:p><jats:bold>Background:\u2002<\/jats:bold>  <jats:italic>Chlamydia trachomatis<\/jats:italic> is the most common bacterial cause of cervicitis.<\/jats:p><jats:p><jats:bold>Aim:\u2002<\/jats:bold> The aim of this randomised, double\u2010blind trial was to compare the effect of vitamin C on dyspareunia and vaginal discharge in women receiving doxycycline and triple sulfa for chlamydial cervicitis.<\/jats:p><jats:p><jats:bold>Methods:\u2002<\/jats:bold> Eighty women with increased anti\u2010<jats:italic>C. trachomatis<\/jats:italic> IgM, reporting abnormal vaginal discharge and dyspareunia, demonstrating signs of cervical oedema and erythema and friability of cervix were included. Thirty\u2010nine women received doxycycline capsules 100\u00a0mg twice daily plus triple sulfa vaginal cream once daily for ten days, and 41 received doxycycline capsules 100\u00a0mg twice\u2013daily and triple sulfa vaginal cream once daily plus vitamin C tablets 250\u00a0mg once daily for ten days. Women were evaluated at follow\u2010up visit, eleventh day, following completion of intervention.<\/jats:p><jats:p><jats:bold>Analysis:\u2002<\/jats:bold> The effect of treatment was assessed regarding clinical criteria (presence of endocervical mucopus and cervical severity score) and presence of dyspareunia. Statistical analysis was carried out using <jats:sc>spss<\/jats:sc> version 11.5.<\/jats:p><jats:p><jats:bold>Results:\u2002<\/jats:bold> The mean age of women was 30.6\u00a0\u00b1\u00a08.4 years. There was no relationship between demographics and dyspareunia and discharge (<jats:italic>P<\/jats:italic>\u00a0&gt;\u00a00.05). There was statistically significant difference between the effect of \u2018doxycycline plus triple sulfa\u2019 and \u2018doxycycline, triple sulfa plus vitamin C\u2019 on discharge and dyspareunia (<jats:italic>P<\/jats:italic>\u00a0=\u00a00.005, <jats:italic>P<\/jats:italic>\u00a0&lt;\u00a00.001, respectively). Most frequently reported drug\u2010related adverse event in both groups was heartburn.<\/jats:p><jats:p><jats:bold>Conclusion:\u2002<\/jats:bold> Adding vitamin C to doxycycline and triple sulfa was more efficient than standard regimen (doxycycline and triple sulfa without vitamin C) in treating chlamydial cervicitis.<\/jats:p>","DOI":"10.1111\/j.1479-828x.2009.01053.x","type":"journal-article","created":{"date-parts":[[2009,9,24]],"date-time":"2009-09-24T04:08:07Z","timestamp":1253765287000},"page":"525-530","update-policy":"http:\/\/dx.doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Randomised double\u2010blind trial of the effect of vitamin C on dyspareunia and vaginal discharge in women receiving doxycycline and triple sulfa for chlamydial cervicitis"],"prefix":"10.1111","volume":"49","author":[{"given":"Marjan","family":"KHAJEHEI","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tahereh","family":"KESHAVARZ","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hamid Reza","family":"TABATABAEE","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2009,9,24]]},"reference":[{"key":"e_1_2_7_2_2","first-page":"32","article-title":"Sexually transmitted disease treatment guidelines","volume":"51","author":"Centers for disease control and prevention","year":"2002","journal-title":"MMWR Recomm Rep"},{"key":"e_1_2_7_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0029-7844(02)02140-3"},{"key":"e_1_2_7_4_2","first-page":"1","article-title":"Sexually transmitted disease treatment guidelines","volume":"42","author":"Centers for Disease Control and Prevention","year":"1993","journal-title":"MMWR Recomm Rep"},{"key":"e_1_2_7_5_2","doi-asserted-by":"publisher","DOI":"10.1093\/humupd\/5.5.433"},{"key":"e_1_2_7_6_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/152.6.1275"},{"key":"e_1_2_7_7_2","doi-asserted-by":"publisher","DOI":"10.3109\/13590849409007233"},{"key":"e_1_2_7_8_2","first-page":"93","article-title":"Chlamydia cervicitis and urethritis: Single dose treatment compared with doxycycline for seven days in community base practices","volume":"72","author":"Thorpe EM","year":"1996","journal-title":"Genitourine Med"},{"key":"e_1_2_7_9_2","volume-title":"Iran Pharma","author":"Shahraz S","year":"2002"},{"key":"e_1_2_7_10_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.93.8.3704"},{"key":"e_1_2_7_11_2","first-page":"756","article-title":"Vitamin C and acute respiratory infections","volume":"3","author":"Hemila H","year":"1999","journal-title":"Int J Tuberc Lung Dis"},{"key":"e_1_2_7_12_2","doi-asserted-by":"publisher","DOI":"10.1191\/0269216305pm970oa"},{"key":"e_1_2_7_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.vetimm.2006.09.004"},{"key":"e_1_2_7_14_2","doi-asserted-by":"publisher","DOI":"10.3181\/00379727-217-44206"},{"key":"e_1_2_7_15_2","doi-asserted-by":"publisher","DOI":"10.3109\/00365549409008582"},{"key":"e_1_2_7_16_2","first-page":"93","article-title":"Chlamydial cervicitis and urethritis: Single dose treatment compared with doxycycline for seven days in community based practices","volume":"72","author":"Thorpe EM","year":"1996","journal-title":"Genitourin Med"},{"key":"e_1_2_7_17_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1479-828X.2000.tb03165.x"},{"key":"e_1_2_7_18_2","doi-asserted-by":"publisher","DOI":"10.1093\/jn\/136.10.2611"},{"key":"e_1_2_7_19_2","doi-asserted-by":"publisher","DOI":"10.2106\/JBJS.F.01147"},{"key":"e_1_2_7_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmv.2007.02.003"}],"container-title":["Australian and New Zealand Journal of Obstetrics and Gynaecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1479-828X.2009.01053.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/obgyn.onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1479-828X.2009.01053.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,13]],"date-time":"2023-10-13T02:41:12Z","timestamp":1697164872000},"score":1,"resource":{"primary":{"URL":"https:\/\/obgyn.onlinelibrary.wiley.com\/doi\/10.1111\/j.1479-828X.2009.01053.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,9,24]]},"references-count":19,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2009,10]]}},"alternative-id":["10.1111\/j.1479-828X.2009.01053.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1479-828x.2009.01053.x","archive":["Portico"],"relation":{},"ISSN":["0004-8666","1479-828X"],"issn-type":[{"value":"0004-8666","type":"print"},{"value":"1479-828X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,9,24]]},"assertion":[{"value":"2009-09-24","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}